Urinary Potassium Excretion and Risk of Developing Hypertension The Prevention of Renal and Vascular End-Stage Disease Study

被引:52
|
作者
Kieneker, Lyanne M. [1 ,2 ,4 ]
Gansevoort, Ron T. [2 ]
Mukamal, Kenneth J. [5 ]
de Boer, Rudolf A. [3 ]
Navis, Gerjan [2 ]
Bakker, Stephan J. L. [1 ,2 ]
Joosten, Michel M. [1 ,2 ]
机构
[1] Top Inst Food & Nutr, Wageningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[4] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands
[5] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA
关键词
diet; epidemiology; hypertension; potassium; primary prevention; risk factors; sodium; BLOOD-PRESSURE; NUTRITIONAL FACTORS; SODIUM-INTAKE; ELECTROLYTE EXCRETION; RACIAL-DIFFERENCES; ALBUMIN EXCRETION; ASSOCIATION; DIET; METAANALYSIS; POPULATION;
D O I
10.1161/HYPERTENSIONAHA.114.03750
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Previous prospective cohort studies on the association between potassium intake and risk of hypertension have almost exclusively relied on self-reported dietary data, whereas repeated 24-hour urine excretions, as estimate of dietary uptake, may provide a more objective and quantitative estimate of this association. Risk of hypertension (defined as blood pressure >= 140/90 mm Hg or initiation of blood pressure-lowering drugs) was prospectively studied in 5511 normotensive subjects aged 28 to 75 years not using blood pressure-lowering drugs at baseline of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study. Potassium excretion was measured in two 24-hour urine specimens at baseline (1997-1998) and midway during follow-up (2001-2003). Baseline median potassium excretion was 70 mmol/24 h (interquartile range, 57-85 mmol/24 h), which corresponds to a dietary potassium intake of approximate to 91 mmol/24 h. During a median follow-up of 7.6 years (interquartile range, 5.0-9.3 years), 1172 subjects developed hypertension. The lowest sex-specific tertile of potassium excretion (men: <68 mmol/24 h; women: <58 mmol/24 h) had an increased risk of hypertension after multivariable adjustment (hazard ratio, 1.20; 95% confidence interval, 1.05-1.37), compared with the upper 2 tertiles (P-nonlinearity = 0.008). The proportion of hypertension attributable to low potassium excretion was 6.2% (95% confidence interval, 1.7%-10.9%). No association was found between the sodium to potassium excretion ratio and risk of hypertension after multivariable adjustment. Low urinary potassium excretion was associated with an increased risk of developing hypertension. Dietary strategies to increase potassium intake to the recommended level of 90 mmol/d may have the potential to reduce the incidence of hypertension.
引用
收藏
页码:769 / +
页数:15
相关论文
共 50 条
  • [1] Urinary Magnesium Excretion and Risk of Hypertension The Prevention of Renal and Vascular End-Stage Disease Study
    Joosten, Michel M.
    Gansevoort, Ron T.
    Mukamal, Kenneth J.
    Kootstra-Ros, Jenny E.
    Feskens, Edith J. M.
    Geleijnse, Johanna M.
    Navis, Gerjan
    Bakker, Stephan J. L.
    HYPERTENSION, 2013, 61 (06) : 1161 - +
  • [2] Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension The Prevention of Renal and Vascular End-Stage Disease Study
    van Ballegooijen, Adriana J.
    Gansevoort, Ron T.
    Lambers-Heerspink, Hiddo J.
    de Zeeuw, Dick
    Visser, Marjolein
    Brouwer, Ingeborg A.
    Kema, Ido P.
    de Borst, Martin H.
    Bakker, Stephan J. L.
    Joosten, Michel M.
    HYPERTENSION, 2015, 66 (03) : 563 - 570
  • [3] Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study
    Kieneker, Lyanne M.
    Hartmann, Oliver
    Bergmann, Andreas
    de Boer, Rudolf A.
    Gansevoort, Ron T.
    Joosten, Michel M.
    Struck, Joachim
    Bakker, Stephan J. L.
    BIOMARKERS, 2018, 23 (05) : 474 - 482
  • [4] Cumulative hypertension burden and risk of end-stage renal disease
    Kim, Chang Seong
    Kim, Bongseong
    Choi, Hong Sang
    Bae, Eun Hui
    Ma, Seong Kwon
    Han, Kyung-Do
    Kim, Soo Wan
    HYPERTENSION RESEARCH, 2021, 44 (12) : 1652 - 1661
  • [5] Sleep duration and risk of end-stage renal disease: the Singapore Chinese Health Study
    Geng, Ting-Ting
    Jafar, Tazeen Hasan
    Yuan, Jian-Min
    Koh, Woon-Puay
    SLEEP MEDICINE, 2019, 54 : 22 - 27
  • [6] Hypertension and end-stage renal disease in the developing world
    El-Khashab, O
    ARTIFICIAL ORGANS, 2002, 26 (09) : 765 - 766
  • [7] Cumulative hypertension burden and risk of end-stage renal disease
    Chang Seong Kim
    Bongseong Kim
    Hong Sang Choi
    Eun Hui Bae
    Seong Kwon Ma
    Kyung-Do Han
    Soo Wan Kim
    Hypertension Research, 2021, 44 : 1652 - 1661
  • [8] PLASMA MAGNESIUM AND RISK OF DIABETES. THE PREVENTION OF RENAL AND VASCULAR END-STAGE DISEASE STUDY
    Schutten, Joelle
    Neto, Gomes Antonio
    Gansevoort, Ron
    de Borst, Martin
    Navis, Gerjan
    Bakker, Stephan J. L.
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 757 - 758
  • [9] Estimated 24-h urinary sodium excretion and risk of end-stage kidney disease
    Shan, Ying
    Bai, Yong
    Zhang, Jingwen
    Lu, Yueqi
    Yu, Sike
    Song, Congying
    Liu, Juehan
    Jian, Min
    Xu, Junjie
    Ding, Changhai
    Xiong, Zuying
    Huang, Xiaoyan
    ISCIENCE, 2023, 26 (05)
  • [10] Salt and hypertension in end-stage renal disease
    Kooman, JP
    Leunissen, KML
    Luik, AJ
    BLOOD PURIFICATION, 1998, 16 (06) : 301 - 311